J.P. Morgan Private Wealth Advisors’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,628
| Closed | -$282K | – | 2026 |
|
|
2022
Q3 | $282K | Sell |
18,628
-1,217
| -6% | -$18.4K | ﹤0.01% | 1676 |
|
|
2022
Q2 | $149K | Sell |
19,845
-598
| -3% | -$4.49K | ﹤0.01% | 1854 |
|
|
2022
Q1 | $186K | Buy |
20,443
+1,743
| +9% | +$15.9K | ﹤0.01% | 1922 |
|
|
2021
Q4 | $131K | Sell |
18,700
-636
| -3% | -$4.46K | ﹤0.01% | 1935 |
|
|
2021
Q3 | $220K | Buy |
19,336
+3,482
| +22% | +$39.6K | ﹤0.01% | 1819 |
|
|
2021
Q2 | $254K | Sell |
15,854
-179
| -1% | -$2.87K | ﹤0.01% | 1732 |
|
|
2021
Q1 | $287K | Sell |
16,033
-793
| -5% | -$14.2K | ﹤0.01% | 1546 |
|
|
2020
Q4 | $227K | Sell |
16,826
-5,380
| -24% | -$72.6K | ﹤0.01% | 1600 |
|
|
2020
Q3 | $261K | Sell |
22,206
-818
| -4% | -$9.61K | ﹤0.01% | 1420 |
|
|
2020
Q2 | $340K | Buy |
23,024
+125
| +0.5% | +$1.85K | ﹤0.01% | 1253 |
|
|
2020
Q1 | $309K | Buy |
22,899
+5,314
| +30% | +$71.7K | ﹤0.01% | 1130 |
|
|
2019
Q4 | $425K | Buy |
17,585
+6,859
| +64% | +$166K | ﹤0.01% | 1111 |
|
|
2019
Q3 | $206K | Buy |
+10,726
| New | +$206K | ﹤0.01% | 1341 |
|
|
2019
Q2 | – | Sell |
-4,856
| Closed | -$231K | – | 1480 |
|
|
2019
Q1 | $231K | Sell |
4,856
-1,259
| -21% | -$59.9K | ﹤0.01% | 1325 |
|
|
2018
Q4 | $221K | Buy |
6,115
+1,740
| +40% | +$62.9K | ﹤0.01% | 1301 |
|
|
2018
Q3 | $269K | Buy |
4,375
+288
| +7% | +$17.7K | ﹤0.01% | 1355 |
|
|
2018
Q2 | $276K | Buy |
+4,087
| New | +$276K | ﹤0.01% | 1236 |
|